United Therapeutics
UTHR
UTHR
373 hedge funds and large institutions have $5.13B invested in United Therapeutics in 2017 Q3 according to their latest regulatory filings, with 39 funds opening new positions, 125 increasing their positions, 142 reducing their positions, and 34 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
12% less repeat investments, than reductions
Existing positions increased: 125 | Existing positions reduced: 142
15% less capital invested
Capital invested by funds: $6.01B → $5.13B (-$884M)
20% less funds holding in top 10
Funds holding in top 10: 5 → 4 (-1)
Holders
373
Holding in Top 10
4
Calls
$69.2M
Puts
$26.2M
Top Buyers
| 1 | +$56M | |
| 2 | +$51M | |
| 3 | +$27.6M | |
| 4 |
JIM
Jupiter Investment Management
London,
United Kingdom
|
+$26.5M |
| 5 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$19.4M |
Top Sellers
| 1 | -$108M | |
| 2 | -$91.5M | |
| 3 | -$51.6M | |
| 4 |
BNP Paribas Financial Markets
Paris,
France
|
-$38M |
| 5 |
LSV Asset Management
Chicago,
Illinois
|
-$35.2M |